Gene · 6336
Papers2,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial transcriptomic profiling of human paravertebral sympathetic chain ganglia reveals diabetes-induced neuroplasticity. | bioRxiv | 2025 | 40667173 | PubTator, text mining | PubMed |
| A novel Nav1.7, Nav1.8, and Nav1.9 blocker, ANP-230, has broad analgesic efficacy in preclinical pain models with favorable safety margins. | Biochem Biophys Res Commun | 2025 | 40633498 | PubTator, text mining | PubMed |
| Voltage-Gated Sodium Channels: A Therapeutic Target in Ischemic Heart Disease. | Rev Cardiovasc Med | 2025 | 40630435 | PubTator, text mining | PubMed |
| From traditional medicine to targeted therapy: Structure-activity relationship-guided optimization of scorpion toxin DKK2 for pain-associated sodium channel blockade. | J Ethnopharmacol | 2025 | 40615098 | PubTator, text mining | PubMed |
| Voltage-Gated Ion Channels in Neuropathic Pain Signaling. | Life (Basel) | 2025 | 40566541 | PubTator, text mining | PubMed |
| Inhibiting Nav1.8 for pain: Lessons from patients and from neurons. | Proc Natl Acad Sci U S A | 2025 | 40549925 | PubTator, text mining | PubMed |
| CXCL13/CXCR5: a new target for pain treatment. | Int J Surg | 2025 | 40540434 | PubTator, text mining | PubMed |
| Suzetrigine: A potential alternative for palliative pain management in Pakistan's opioid-restricted healthcare system. | J Oncol Pharm Pract | 2025 | 40491298 | PubTator, text mining | PubMed |
| Molecular genetic analysis of pulmonary benign metastasizing leiomyoma and intravenous leiomyomatosis: a comparative study using whole exome sequencing. | Discov Oncol | 2025 | 40434516 | PubTator, text mining | PubMed |
| Nav1.8 and Chronic Pain: From Laboratory Animals to Clinical Patients. | Biomolecules | 2025 | 40427587 | PubTator, text mining | PubMed |
| Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine. | Proc Natl Acad Sci U S A | 2025 | 40424150 | PubTator, text mining | PubMed |
| The Identification of Opioid Receptors and Peptide Precursors in Human DRG Neurons Expressing Pain-Signaling Molecules Confirms Their Potential as Analgesic Targets. | Cells | 2025 | 40422197 | PubTator, text mining | PubMed |
| Heritability and causality of QRS duration and chronic heart failure risk. | ESC Heart Fail | 2025 | 40350543 | PubTator, text mining | PubMed |
| Effect of pain-related sodium channels SCN9A and SCN10A polymorphisms in migraine chronification. | Neurol Res | 2025 | 40348737 | PubTator, text mining | PubMed |
| Pharmacological Frontiers: The Rise of Selective NaV1.8 Inhibition for Pain Management. | CNS Drugs | 2025 | 40325338 | PubTator, text mining | PubMed |
| Suzetrigine: First Approval. | Drugs | 2025 | 40323340 | PubTator, text mining | PubMed |
| Genetic Variants and Clinical Phenotyping in 39 Pediatric Patients with Neuropathic Pain. | Neuropediatrics | 2025 | 40294637 | PubTator, text mining | PubMed |
| Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine). | J Gen Physiol | 2025 | 40294084 | PubTator, text mining | PubMed |
| Inherent fast inactivation particle of Nav channels as a new binding site for a neurotoxin. | EMBO J | 2025 | 40263599 | PubTator, text mining | PubMed |
| Humanized NaV1.8 rats overcome cross-species potency shifts in developing novel NaV1.8 inhibitors. | Neurobiol Pain | 2025 | 40213630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6336/papers?page=8